Accession Number: | 0001209191-20-009837 |
Date: | 2020-02-13 |
Issuer: | ARENA PHARMACEUTICALS INC (ARNA) |
Original Submission Date: |
SPECTOR STEVEN W
C/O ARENA PHARMACEUTICALS, INC.
6154 NANCY RIDGE DRIVE
SAN DIEGO, CA 92121
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-02-13 | M | 2,472 | a | $32.50 | 15,339 | direct | ||
COMMON STOCK | 2020-02-13 | M | 4,964 | a | $37.20 | 20,303 | direct | ||
COMMON STOCK | 2020-02-13 | S | 10,836 | d | $55.00 | 9,467 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 32.5 | 2020-02-13 | deemed execution date | M | 2,472 (d) | 2020-03-17 | common stock 2,472 | $32.50 | 1,254 | direct | ||
EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 37.2 | 2020-02-13 | deemed execution date | M | 4,964 (d) | 2021-12-15 | common stock 4,964 | $37.20 | 2,536 | direct |
ID | footnote |
---|---|
f1 | the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan established by the reporting person. |
f2 | the options vested in four equal annual installments (except as otherwise necessary to avoid vesting of a fractional share) beginning on march 17, 2011, and ending on march 17, 2014, and became exercisable once vested. |
f3 | the options vested in four equal annual installments (except as otherwise necessary to avoid vesting of a fractional share) beginning on december 15, 2015, and ending on december 15, 2018, and became exercisable once vested. |